A late-night bidding war for a Californian biotech company has taken the value of healthcare deals in the past 15 months to nearly half a trillion dollars in a fresh sign that sky-high valuations have not slowed the pace of pharmaceuticals dealmaking.
對美國加州一家生物科技公司的深夜競標戰，使過去15個月的醫藥業併購交易總值逼近5000億美元，這一最新跡象表明，天價估值並未放緩製藥業撮合交易的步伐。
您已閱讀7%（326字），剩餘93%（4157字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。